| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |